279 related articles for article (PubMed ID: 31414551)
1. Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis.
Zhou BG; Chen LX; Li B; Wan LY; Ai YW
Helicobacter; 2019 Oct; 24(5):e12651. PubMed ID: 31414551
[TBL] [Abstract][Full Text] [Related]
2. Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection.
Szajewska H; Horvath A; Kołodziej M
Aliment Pharmacol Ther; 2015 Jun; 41(12):1237-45. PubMed ID: 25898944
[TBL] [Abstract][Full Text] [Related]
3. The effect of Saccharomyces boulardii supplementation on Helicobacter pylori eradication in children: a systematic review and meta-analysis of Randomized controlled trials.
Liu LH; Han B; Tao J; Zhang K; Wang XK; Wang WY
BMC Infect Dis; 2023 Dec; 23(1):878. PubMed ID: 38102568
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.
Lü M; Yu S; Deng J; Yan Q; Yang C; Xia G; Zhou X
PLoS One; 2016; 11(10):e0163743. PubMed ID: 27723762
[TBL] [Abstract][Full Text] [Related]
5. Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: a randomized, open-label trial.
Seddik H; Boutallaka H; Elkoti I; Nejjari F; Berraida R; Berrag S; Loubaris K; Sentissi S; Benkirane A
Eur J Clin Pharmacol; 2019 May; 75(5):639-645. PubMed ID: 30694338
[TBL] [Abstract][Full Text] [Related]
6. A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children.
Hurduc V; Plesca D; Dragomir D; Sajin M; Vandenplas Y
Acta Paediatr; 2009 Jan; 98(1):127-31. PubMed ID: 18681892
[TBL] [Abstract][Full Text] [Related]
7. Saccharomyces boulardii combined with triple therapy alter the microbiota in the eradication of Helicobacter pylori infection.
Zhang Y; Lu B; Dong Y; Zhang Y; Du Q; Chen Y; Zhang Z
Sci Rep; 2024 Jun; 14(1):13152. PubMed ID: 38849408
[TBL] [Abstract][Full Text] [Related]
8. Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis.
Zhang MM; Qian W; Qin YY; He J; Zhou YH
World J Gastroenterol; 2015 Apr; 21(14):4345-57. PubMed ID: 25892886
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
Cindoruk M; Erkan G; Karakan T; Dursun A; Unal S
Helicobacter; 2007 Aug; 12(4):309-16. PubMed ID: 17669103
[TBL] [Abstract][Full Text] [Related]
10. Investigating the effect of quadruple therapy with Saccharomyces boulardii or Lactobacillus reuteri strain (DSMZ 17648) supplements on eradication of Helicobacter pylori and treatments adverse effects: a double-blind placebo-controlled randomized clinical trial.
Naghibzadeh N; Salmani F; Nomiri S; Tavakoli T
BMC Gastroenterol; 2022 Mar; 22(1):107. PubMed ID: 35255819
[TBL] [Abstract][Full Text] [Related]
11. The effect of supplementing with
Chen Y; Teng T; Su Y; Chen WZ
Front Med (Lausanne); 2024; 11():1344702. PubMed ID: 38695028
[TBL] [Abstract][Full Text] [Related]
12. [Influence of different timing of
He CX; Kong FT; Liang F; Wang KX; Li H; Liu YL; Zhao W; Zhou PP; Kong FL
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(22):1731-1734. PubMed ID: 31216821
[No Abstract] [Full Text] [Related]
13. The effect of probiotics and mucoprotective agents on PPI-based triple therapy for eradication of Helicobacter pylori.
Song MJ; Park DI; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
Helicobacter; 2010 Jun; 15(3):206-13. PubMed ID: 20557362
[TBL] [Abstract][Full Text] [Related]
14. Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome.
Cárdenas PA; Garcés D; Prado-Vivar B; Flores N; Fornasini M; Cohen H; Salvador I; Cargua O; Baldeón ME
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1365-1372. PubMed ID: 32125555
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Lactobacillus-supplemented triple therapy for Helicobacter pylori infection in children: a meta-analysis of randomized controlled trials.
Fang HR; Zhang GQ; Cheng JY; Li ZY
Eur J Pediatr; 2019 Jan; 178(1):7-16. PubMed ID: 30446816
[TBL] [Abstract][Full Text] [Related]
16. [Clinical effect of triple therapy combined with Saccharomyces boulardii in the treatment of Helicobacter pylori infection in children].
Zhao HM; Ou-Yang HJ; Duan BP; Xu B; Chen ZY; Tang J; You JY
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Mar; 16(3):230-3. PubMed ID: 24661511
[TBL] [Abstract][Full Text] [Related]
17. Allicin as add-on therapy for
Si XB; Zhang XM; Wang S; Lan Y; Zhang S; Huo LY
World J Gastroenterol; 2019 Oct; 25(39):6025-6040. PubMed ID: 31660038
[TBL] [Abstract][Full Text] [Related]
18. Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance.
Çekin AH; Şahintürk Y; Akbay Harmandar F; Uyar S; Yolcular BO; Çekin Y
Turk J Gastroenterol; 2017 Jan; 28(1):3-11. PubMed ID: 28007678
[TBL] [Abstract][Full Text] [Related]
19. Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori eradication therapy for functional dyspepsia: Systematic review and meta-analysis.
Du LJ; Chen BR; Kim JJ; Kim S; Shen JH; Dai N
World J Gastroenterol; 2016 Mar; 22(12):3486-95. PubMed ID: 27022230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
